[Elsevier] Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study |
|
This post will be closed automatically in 2026-03-06 21:52
Best Answer
4 day(s) ago
|
| |
| |
10
hERGBoost: A gradient boosting model for quantitative IC50 prediction of hERG channel blockers
10
Thixotropy in food systems: A study on mayonnaise
10
Emerging innovations in cold plasma therapy against cancer: A paradigm shift
10
Managing Epistaxis
20
LFT-Net: A lightweight frequency-based transformer for low-light enhancement and exposure correction
